Treatment of vasculitis;Therapie der Vaskulitis

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 31-32, 1996, Pages 985-987

  Andrassy, K ^a   Waldherr, R ^a,b   Hergesell, O ^a   Ritz, E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; IMMUNOMODULATING AGENT; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; THYMOCYTE ANTIBODY;

DOSE CALCULATION; DRUG FORMULATION; HUMAN; IMMUNOPATHOGENESIS; ORAL DRUG ADMINISTRATION; SHORT SURVEY; T LYMPHOCYTE; VASCULITIS;

EID: 0029959337     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024017     Document Type: Short Survey

References (14)

1. Andrassy, K., A. Erb, J. Koderisch, R. Waldherr, E. Ritz: Wegener's granulomatosis with renal involvement. Patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin. Nephrol. 35 (1991), 139-147.
2. Andrassy, K., N. Rasmussen: Treatment of granulomatous disorders of the nose and paranasal sinuses. Rhinology 27 (1989), 221-230.
3. Austin, H. A., J. H. Klippel, J. E. Balow, N. G. de Riche, A. D. Steinberg, P. H. Plotz, J. L. Decker: Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. New Engl. J. Med. 314 (1986), 614-619.
4. Fauci, A. S., B. F. Haynes, P. Katz, S. M. Wolff: Wegener's granulomatosis. Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann. intern. Med. 98 (1983), 76-85.
5. Gross, W. L.: Vaskulitiden. Dtsch. Ärztebl. 92 (1995), 1019-1026.
6. Gross, W. L., N. Rasmussen: Treatment of Wegener's granulomatosis. The view from two non-nephrologists. Nephrol. Dialys. Transplant. 9 (1994), 1219-1225.
7. Hagen, E. C., R. J. W. de Keizer, K. Andrassy, W. P. L. van Boven, J. A. Bruijn, L. A. van Es, F. J. van der Woude: Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin. Clin. Nephrol. 43 (1995), 351-359.
8. Haubitz, M., U. Frei, U. Rother, R. Brunkhorst, K. M. Koch: Cyclophosphamide pulse therapy in Wegener's granulomatosis. Nephrol. Dialys. Transplant. 6 (1991), 531-535.
9. Jayne, D. R. W., M. J. Davies, C. J. V. Fox, C. M. Black, C. M. Lockwood: Treatment of systemic vasculitis with pooled intravenous immunoglobulins. Lancet 337 (1991), 1137-1139.
10. Lockwood, C. M., S. Thiru, J. D. Isaacs, G. Hale, H. Waldmann: Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet 341 (1993), 1620-1622.
11. Martindale: The extra pharmacopoeia. In Reynolds, J. E. F. (Ed.): Antineoplastic Agents and Immunosuppression (Pharmaceutical Press: London 1993), 457-458.
12. Rasmussen, N., D. R. Jayne, D. Abramowicz, K. Andrassy: European therapeutic trials in ANCA-associated systemic vasculitis. Disease scoring, consensus regimens and proposed clinical trials. Clin. exp. Immunol. 101, Suppl. 1 (1995), 29-34.
13. Schnabel, A., W. L. Gross: Low-dose methotrexat in rheumatic diseases. Efficacy, side effects and risk factors for side effects. Semin. Arthr. Rheum. 23 (1994), 310-327.
14. Sneller, M. C., G. S. Hoffman, C. Talar-Williams, G. S. Kerr, C. W. Hallahan, A. S. Fauci: An analysis of forty-two Wegener's granulomatosis patients treated with methotrexat and prednisone. Arthr. and Rheum. 38 (1995), 608-613.